Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

JAVIER MONCLÚS, CARLOS LABARTA, CARMEN DÍEZ, LUIS AGUSTÍN E IÑAKI BERGERA - Paisajes urbanos residenciales en la Zaragoza contemporánea

View through CrossRef
JAVIER MONCLÚS, CARLOS LABARTA, CARMEN DÍEZ, LUIS AGUSTÍN E IÑAKI BERGERAPaisajes urbanos residenciales en la Zaragoza contemporáneaZaragoza: Prensas de la Universidad de Zaragoza, 2013, 161 págs. Idioma: español
Universidad de Zaragoza
Title: JAVIER MONCLÚS, CARLOS LABARTA, CARMEN DÍEZ, LUIS AGUSTÍN E IÑAKI BERGERA - Paisajes urbanos residenciales en la Zaragoza contemporánea
Description:
JAVIER MONCLÚS, CARLOS LABARTA, CARMEN DÍEZ, LUIS AGUSTÍN E IÑAKI BERGERAPaisajes urbanos residenciales en la Zaragoza contemporáneaZaragoza: Prensas de la Universidad de Zaragoza, 2013, 161 págs.
Idioma: español.

Related Results

Paisajes urbanos residenciales en la Zaragoza contemporánea
Paisajes urbanos residenciales en la Zaragoza contemporánea
En la literatura arquitectónica y urbana internacional, abundan los trabajos sobre los procesos de crecimiento y sobre el papel de la vivienda en la definición del paisaje urbano c...
Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal
Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal
Abstract The fundamental value of universal nomenclatural systems in biology is that they enable unambiguous scientific communication. However, the stability of thes...
Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy
Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy
Abstract Background The World Health Organization (WHO) Surgical Safety Checklist has fostered safe practice for 10 years, yet i...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...

Back to Top